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Abstract
Scaffolds populated with human cardiac progenitor cells (CPCs) represent a therapeutic
opportunity for heart regeneration after myocardial infarction. In this work, square-grid scaf-
folds are prepared by melt-extrusion additive manufacturing from a polyurethane (PU), fur-
ther subjected to plasma treatment for acrylic acid surface grafting/polymerization and
finally grafted with laminin-1 (PU-LN1) or gelatin (PU-G) by carbodiimide chemistry. LN1 is a
cardiac niche extracellular matrix component and plays a key role in heart formation during
embryogenesis, while G is a low-cost cell-adhesion protein, here used as a control functio-
nalizing molecule. X-ray photoelectron spectroscopy analysis shows nitrogen percentage
increase after functionalization. O1s and C1s core-level spectra and static contact angle
measurements show changes associated with successful functionalization. ELISA assay
confirms LN1 surface grafting. PU-G and PU-LN1 scaffolds both improve CPC adhesion,
but LN1 functionalization is superior in promoting proliferation, protection from apoptosis
and expression of differentiation markers for cardiomyocytes, endothelial and smooth mus-
cle cells. PU-LN1 and PU scaffolds are biodegraded into non-cytotoxic residues. Scaffolds
subcutaneously implanted in mice evoke weak inflammation and integrate with the host tis-
sue, evidencing a significant blood vessel density around the scaffolds. PU-LN1 scaffolds
show their superiority in driving CPC behavior, evidencing their promising role in myocardial
regenerative medicine.
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Introduction
Coronary artery disease is the leading mortality cause in the world with more than 4 million
Europeans dying every year [1]. Despite the significant advances in pharmaceutical and interven-
tional approaches, existing therapies cannot compensate for cardiomyocyte loss and myocardial
function decrease. In the last decades, several groups have identified and isolated resident cardiac
primitive cells (CPCs) in the heart tissue [2–5], using a variety of cell surface markers, among
which the stem cell factor receptor c-kit (CD117) [6–8]. Since then, the possibility of myocardial
regeneration driven by resident or implanted CPCs has appeared as a new intriguing strategy.
However, cell therapies using different cell types including CPCs [9] have shown poor cell reten-
tion and survival at the implant site and limited improvement of heart contractility attributed to
a paracrine effect exerted by the implanted cells on the resident cells [10, 11]. Scaffold-based
strategies are also under investigation for myocardial regeneration and could be exploited to
develop CPC-populated patches or scaffolds able to recruit endogenous CPCs [12, 13]. Accord-
ing to the general principle of tissue engineering (TE), 3D scaffolds with biomimetic mechanical,
structural and chemical properties respect to the natural extracellular matrix (ECM) should
induce stem cells to attach, proliferate and differentiate into the desired cell phenotypes [14].
Stem cells exist in vivo in a specialized microenvironment, the stem cell niche, controlling their
proliferation and differentiation [15, 16]. Hence, a promising approach to regulate CPC behavior
is to engineer scaffolds mimicking the cardiac niche ECM. Mauretti and colleagues have recently
published a review focused on the definition and properties of resident CPCs, highlighting the
key components of CPC niches and the interplay of CPCs with niche constituents [17]. In 2012,
Kim et al. first exploited nanofabrication technologies to design surface nanopatterned dense
films mimicking cardiac matrix topographical properties, thus creating a stem cell niche in vitro
and increasing the myogenic differentiation of progenitor cells cultivated on the developed sub-
strates [18]. A further step in the thorough understanding of the key role exerted by nanotopo-
graphy on cardiac cell behavior has been done by Mengstead and colleagues that demonstrated
the capability of cardiomyocytes to align their contractile direction to substrate nanotopography
and reorganize it in response to matrix topography changes [19]. The combination of anisotropic
topography and electrical conductivity has recently shown to increase the expression of cell-cell
coupling and calcium handling proteins, action potential duration, peak calcium release [20]. In
addition to surface topography, CPC culture in a three-dimensional environment has been dem-
onstrated to enhance the expression of cardiac transcription factors compared to traditional 2D
culture conditions [21–25]. From a biochemical point of view, Castaldo et al. [26] have recently
found that human cardiac fibroblasts (CFs) isolated from human heart tissue can deposit in vitro
a “biomatrix”, with chemical properties similar to the cardiac niche ECM. Studies on the interac-
tion of CPCs with the “biomatrix” constituent proteins have shown that laminin-1 (LN1) pro-
tects CPCs from apoptosis and stimulates their proliferation [27]. LN1 has important role for
heart development during embryogenesis [28] and has been found to enhance Caco-2 cell differ-
entiation [29]. Up to now, LN1 has been widely used in TE, especially for nerve regeneration [30,
31], while no literature exists on its use for scaffold functionalization in the field of myocardial
TE to promote CPC differentiation, as proposed in this work.
In cardiac TE, the use of CPCs isolated from adult tissues or derived from pluripotent stem
cells is still limited [23–25, 32, 33]. Particularly, for CPCs derived from embryonic or induced
pluripotent stem cells, safety concerns also arise due to the possible uncontrolled differentia-
tion of any residual pluripotent stem cells. Hence, an accurate control of the differentiation
protocol of pluripotent stem cells is needed [34].
Among the previous studies on cardiac TE strategies exploiting CPC potentialities,
Forte et al. have investigated the effects of microfabricated scaffold topography on CPC
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determinants of aging to design new therapeutics -
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differentiation in the presence of a medium enriched with cardiomyocyte-differentiation factors
[23]. Gaetani et al. have fabricated bioprinted alginate constructs encapsulating CPCs, demon-
strating partial differentiation of CPCs to cardiomyocytes in vitro [24]. Cristallini et al. have
reported that bioartificial scaffolds based on poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/gel-
atin with a biomimetic architecture induce the partial differentiation of cardiac resident cells
into the cardiac lineage in vitro [25]. Recently, we have prepared scaffolds based on an elasto-
meric polyurethane (PU) by melt-extrusion additive manufacturing (AM), which showed the
ability to support CPC adhesion and viability, while they were unable to stimulate CPC prolifer-
ation [35]. The aim of the present work was to investigate the effects of PU scaffolds surface
functionalized with LN1 (PU-LN1 scaffolds) on CPC response, in the future perspective of a
CPC therapy exploiting scaffolds. LN1 was chosen to provide PU scaffolds with biomimetic
cues of the cardiac ECM, while gelatin (G) -another ECM derivative widely used in TE, but not
providing cardiac-specific cues- was used as a control functionalizing molecule for PU scaffolds
(PU-G scaffolds). Successful surface functionalization was assessed by X-ray Photoelectron
Spectroscopy (XPS), colorimetric assays (toluidine blue assay, Enzyme-linked immunosorbent
(ELISA) assay) and surface wettability measurements. Accelerated in vitro degradation tests
were carried out with lipase to prove scaffold degradability and assess the effects of surface func-
tionalization on degradation kinetics; the cytocompatibility of scaffold degradation products
was also demonstrated according to ISO rules (ISO 10993–5). CPC adhesion, proliferation and
apoptosis on PU, PU-LN1 and PU-G scaffolds was assessed by morphological evaluation and
by identifying and quantifying actively cycling Ki67-positive cells. CPC differentiation was eval-
uated through the expression of typical markers of primitive cardiomyocyte, endothelial cell
and smooth muscle cell lineages by Real-Time Quantitative Reverse Transcription-Polymerase
Chain Reaction (RT-PCR). Finally, PU and PU-LN1 scaffolds were subcutaneously implanted
in mice to assess their biocompatibility and evaluate tissue response to the implantation of
newly designed porous matrices. Furthermore, the effects of surface functionalization on body
reaction (e.g. inflammation, integration, vascularisation) were also studied.
The innovative contribution of this work was the use of biomimetic scaffold functionaliza-
tion with LN1, rather than a differentiation medium [23–25, 32] or biomimetic anisotropic
architecture [25] to enhance CPC survival and differentiation potential.
Experimental
Polyurethane synthesis
A thermoplastic polyurethane (PU; Mn: 80000 Da; Mw/Mn: 1.5) was synthesized from PCL
diol (Across Organics, Germany, Mn = 2000 Da), 1,4-butane diisocyanate (BDI) (AlloraChem,
Italy) and L-lysine ethyl ester dihydrochloride (Sigma-Aldrich, Italy) chain extender, according
to a method described in previous publications [35, 36].
Scaffold and film preparation. Three-dimensional scaffolds were fabricated using a cus-
tom-designed AM equipment [37, 38], as previously described by Chiono et al. [35]. The appa-
ratus comprises a heated dispensing head terminated with a nozzle, a X–Y motorized stage for
the positioning of the dispensing head, and a Z-axis for controlling its distance from the stage.
The extrusion process was performed by dispensing the polymer in a molten form through a
150 μm nozzle at 8 bar, 155˚C, with a 2 mms-1 relative speed between the nozzle and the X-Y
stage. Generation of the process tool-path was performed starting from a CAD geometry using
a dedicated software interface. Scaffolds with a homogeneous grid structure were fabricated by
depositing two layers of fibers laminated in a 0/90˚ pattern. For each layer, the inter-axial fiber
spacing was 500 μm. PU film samples were prepared by melt-compression as previously
described by Boffito el al. [39] and used for the optimization of the grafting protocols.
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Protein functionalization. Round shaped PU films and scaffolds (6 mm in diameter)
were functionalized with G (type A from porcine skin, Sigma-Aldrich, Italy) and mouse LN1
(from Murine Engelbreth-Holm-Swarm tumor, Cultrex, USA) according to the following
method, based on a two-step plasma treatment (Diener Electronic, Pico Low Pression Plasma
System, Germany) [40]. Initially, the samples were treated with Argon plasma (50 W, 0.7
mbar, 20 sccm) for 5 min to create radical species on their surface. Then, they were immedi-
ately subjected to acrylic acid (Sigma-Aldrich, Italy) plasma treatment (50 W, 0.05 mbar, 45
sccm) for 15 min with the aim to graft and polymerize acrylic acid on their surface. By this
method, the surface was enriched with -COOH groups, which were then exploited for the
covalent grafting of G and LN1. To this purpose, samples were placed in an aqueous solution
(pH 5.0) containing 5 mg/mL of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC;
Sigma-Aldrich, Italy) and 1.25 mg/mL of N-hydroxysuccinimide (NHS; Sigma-Aldrich, Italy)
at 4˚C for 20 h [40]. Scaffolds were then washed 3 times with deionized water (DIW). Finally,
LN1 and G were covalently grafted on previously activated sample surfaces by 20 h incubation
in G and LN solutions (10 μg/ml) in phosphate buffered saline (PBS; Sigma-Aldrich, Italy) at
room temperature. Samples were withdrawn and rinsed three times with DIW.
Physico-chemical characterizations of polyurethane scaffolds
Morphological characterization. Scaffold morphology was analyzed by FEG-SEM (LEO
Supra 1535). Samples were mounted on aluminum stubs, coated with a conductive layer of
sputtered gold (Emitech K550 sputter coater) and observed at 5 kV accelerating voltage. Aver-
age filament diameter and spacing were calculated from SEM images (IMAGEJ; National Insti-
tutes of Health, Bethesda, MD, USA) and expressed as a mean value ± standard deviation
(n>20).
Chemical surface characterization. To assess the successful surface functionalization,
XPS was performed on pristine PU, PU after plasma-polymerized acrylic acid coating
(plasma-treated PU), PU-G and PU-LN1 scaffolds using a PHI 5000 Versaprobe instrument in
a high vacuum chamber at a power of 25.6 W and a voltage of 23.5 eV, with a scanning area of
100x100 μm2. Analysis of XPS spectra was performed using XPSPEAK 4.1 software. TBO col-
orimetric assay was performed to quantify the–COOH groups on the surface of plasma-treated
PU compared to pristine PU [41, 42]. Samples were soaked into 500 μM TBO (Sigma-Aldrich,
Italy) aqueous solution (pH 10). The formation of ionic complexes between -COOH groups
and the cationic dye was allowed to proceed for 12 hours at room temperature. Samples were
then rinsed with 0.1 mM NaOH solution (pH 10) to remove unbound TBO molecules. The
bonded TBO was desorbed by incubation in 50% acetic acid solution for 25 min. Solution
absorbance at 632 nm was recorded in an UV-Vis spectrophotometer (PerkinElmer, Lambda
25). The amount of–COOH groups was calculated by a calibration curve derived from TBO
solutions in acetic acid/water (50% v/v) at selected concentrations in the 2.5 25 μM range,
and based on the assumption that 1 mol TBO interacts with 1 mol–COOH. Experiments were
performed in quintuplicate and results are reported as mean value ± standard deviation.
Finally, surface functionalization with LN1 was also evaluated through Enzyme-linked immu-
nosorbent (ELISA) assay. To obtain a standard curve, different wells of microtiter plates were
coated with an amount of LN1 solution in PBS with increasing concentrations (0.025, 0.05,
0.075, 0.1, 0.25, 0.5, 0.75 and 1 mg/mL) overnight at 4˚C. Coated wells of microtiter plates and
PU and PU-LN1 scaffolds were washed three times with PBS and then incubated with PBS
containing 5% bovine serum albumin (BSA; Sigma-Aldrich, Italy) at room temperature for 1
h. After washing, they were incubated with rabbit anti-laminin 1 antibody (Abcam ab11575,
UK) at 1:10,000 dilution in PBS containing 5% BSA for 1 h. After washing, samples were
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incubated with a horseradish perodixase (HRP)-coupled goat anti-rabbit antibody (A6154;
Sigma-Aldrich, Italy) 1:800 diluted in 5% BSA solution in PBS for 1 h. 90 μl of a 3,3’,5,50-tetra-
methylbenzidine (TMB; T0440, Sigma-Aldrich, Italy) solution in dimethyl sulfoxide (DMSO,
Sigma-Aldrich, Italy) was added to each well, and the reaction was stopped after 2 min by addi-
tion of 90 mL of 0.5 N HCl (Sigma-Aldrich, Italy). Absorbance was read at 450 nm in a micro-
titer plate reader (GloMax-Multidetection System, Promega). The standard curve was
generated using a second order polynomial equation using GraphPad Prism (GraphPad Soft-
ware, La Jolla California USA, www.graphpad.com). LN1 concentrations were deduced trough
regression analysis.
Surface wettability. Static contact angle was measured on film samples at room tempera-
ture, using 5 μL DIW droplets by a video contact angle system in a KSV instrument equipped
with a CAM 200 software for data acquisition. Sessile drop method was applied. For each sam-
ple, three measurements on different surface zones were averaged. Data are reported as mean
value ± standard deviation.
In vitro degradation tests. Hydrolytic and enzymatic degradation tests using lipase (from
porcine pancreas, Sigma-Aldrich, Italy) were performed weekly on PU and PU-LN1 scaffolds
(6 mm diameter) up to 8 weeks. Degradation tests were carried out at 37˚C under stirring at
50 rpm. The samples were placed in vials containing 0.1 ml PBS (pH 7.4) per mg sample in the
case of hydrolytic tests, and 0.3 mg/mL lipase in PBS in the case of enzymatic tests. The degra-
dation medium was renewed every 3 days. At each time point, three samples were withdrawn,
washed with DIW and then dried at 37˚C. Weight loss percentage was measured according to
the formula:
%weight loss ¼
W0   W
W0
 100 ð1Þ
where W0 is sample initial weight and W is the weight at each time point during the test.
At each time point, Mn loss percentage was also measured:
%Mn loss ¼
Mn0   Mn
Mn0
 100 ð2Þ
where Mn0 is the initial number average molecular weight, while Mn is the number average
molecular weight at each time during the test. Mn was evaluated by Size Exclusion Chromatog-
raphy (SEC; Agilent Technologies 1200 Series, USA), according to a previously published pro-
tocol [30]. Every two weeks, sample surface and cross section were also analyzed by SEM (LEO
1450VP). All samples were gold-coated before analysis and micrographs were taken with a
beam voltage of 20 kV and a magnification of 80x and 300x for surfaces and 350x for cross
sections.
Cytotoxicity of degradation products. Pristine PU scaffolds (6 mm diameter) were
placed in vials containing 0.1 mL lipase solution (0.3 mg/mL in PBS) per mg and incubated at
37˚C. Every three days, the degradation medium was changed, collected, and stored at -20˚C.
After complete degradation, the collected medium was thawed and lipase was deactivated by
treating degradation medium for 2 hours at 65˚C. PU degradation products were dehydrated
by freeze drying (Martin Christ ALPHA 2–4 LSC) for 48 h. Powders were solubilized in cell
medium and filtered in 0.22 μm membrane filters (Millex 33 mm Sterile Filter Unit with Milli-
pore Express PES Membrane). 2×103 NIH-3T3 mouse embryonic fibroblasts were seeded on
96-well plates in DMEM (Thermofisher, Italy), supplemented with 10% fetal bovine serum
(FBS; MANUF), 100 U/mL penicillin (MANUF), and 100 μg/mL streptomycin (Sigma
Aldrich, Italy) with or without 0.1 mg/mL PU degradation products. At each time point (0, 2,
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4, 6 days), cells were washed with PBS to remove the medium, then 300 μL of the Cell Titer
Blue/cell culture medium mixture (20% v/v) was added to each sample. Cell Titer Blue assay
was performed following manufacturer’s recommendations. After 30 min, 100 μL of superna-
tant from each well were transferred to a new 96-well plate and fluorescence was measured
using a GloMax-Multidetection System (Promega) at excitation wavelength (λex) of 525 nm
and emission wavelength (λem) of 580–640 nm.
In vitro cell tests
Isolation of cardiac progenitor cells. Cardiac tissue samples were obtained from the atria
of pathological hearts, which were explanted from patients with end-stage heart failure due to
ischemic cardiomyopathy (n = 22, mean age 55.8 ± 3.1 years, 16 males, 6 females, mean ejec-
tion fraction 25 ± 1%) as a part of heart transplantation procedures. Specimens were collected
without patient identifiers in accordance with the requirements approved by Monaldi Hospital
and in conformity with the principles outlined in the Declaration of Helsinki. The samples
were collected and anonymously provided by Monaldi Hospital (Naples, Italy). Cardiac tissue
samples were dissected, minced, and then enzymatically disaggregated by incubation in 0.25
trypsin and 0.1 (%w/v) collagenase II (Sigma Aldrich, Italy) for 30 min at 37˚C. Enzyme activ-
ity was stopped by adding a double volume of Hank’s balanced salt solution (HBSS; Sigma-
Aldrich) supplemented with 10% FBS (Sigma Aldrich, Italy). Next, the tissue suspension was
further disaggregated by pipetting and tissue debris and cardiomyocytes were removed by
sequential centrifugation at 100 ×g for 2 min, passage through a 20 μm sieve, and centrifuga-
tion at 400 ×g for 5 min. Cells were then seeded on culture plates in DMEM/Nutrient Mixture
F-12 (DMEM/F-12, Sigma-Aldrich, Italy) supplemented with 10% FBS, basic fibroblast growth
factor (Peprotech, Rocky Hill, NJ, USA), glutathione (Sigma-Aldrich, Italy), penicillin and
streptomycin (Life Technologies, Paisley, UK). Cells were cultured for a period ranging from 1
to 2 weeks. Once cells reached 75% confluence, they were detached with 0.25% trypsin-ethyl-
enediaminetetraacetic acid (trypsin-EDTA;, Sigma-Aldrich, Italy). Finally, CPCs were isolated
from cell suspension by immuno-magnetic cell sorting with anti-human-CD117 microbeads
(Miltenyi Biotec, Bergisch Gladbach, Germany).
Scaffold cell seeding. CPCs were seeded on PU, PU-LN1 and PU-G scaffolds, previously
sterilized by UV exposure (20 min for each side), in 96-well plates at a density of 7×104 cells/
cm2. Constructs were observed under an inverted phase contrast microscope (CKX41; Olym-
pus Italia, Segrate, Italy) equipped with a digital camera (Color View IIIu Soft Imaging System,
Muenster, Germany) during in vitro cell tests (7, 14 and 21 days).
Scaffold processing for microscopy. CPCs cultured on the scaffolds for 7, 14 and 21 days
were fixed in 4% paraformaldehyde (PFA; Merck, Germany) for 20 min at room temperature,
incubated with 30% sucrose (Sigma-Aldrich) at 4˚C overnight and embedded in Tissue Freez-
ing Medium (TFM, Leica Biosystems, Italy) in disposable molds (Bio-Optica, Italy). For quick
freezing, molds were immersed in liquid nitrogen until TFM turned solid white and then
stored at -80˚C until cryosectioning. Slices of 10 μm were cut in a cryostat at -20˚C and cryo-
sections were collected on a microscope slide.
CPC immunofluorescence staining. Sections were incubated with primary anti-human
antibodies against Ki67 (mouse monoclonal, Leica Microsystems), followed by secondary
antibodies conjugated with fluorescein or rhodamine. Actin was revealed with FITC-labelled
phalloidin (Jackson ImmunoResearch Europe, UK) and nuclei were counterstained with
4’,6-diamidino-2-phenylindole (DAPI; Merck Millipore, Germany) or propidium iodide
(Sigma-Aldrich, Italy). DAPI staining was also used for the identification of apoptotic bodies
in apoptosis evaluation.
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Morphological analysis. CPC adhesion on scaffolds was analyzed by SEM at 7 and 14
days, following a reported procedure [43, 44]. Briefly, constructs were fixed in 3% glutaralde-
hyde solution (Sigma-Aldrich, Italy) for 15 min at room temperature, followed by post-fixation
with 1% osmium tetroxide (Sigma-Aldrich, Italy) for 15 min. After washing in PBS, specimens
were dehydrated by graded alcohol series, followed by critical point drying (Emitech K850,
Quorum Technologies, UK). Specimens were mounted on aluminium stubs with adhesive car-
bon tape and gold-sputtered prior to observation performed with an acceleration voltage of 5
kV at a working distance of 13 mm.
Gene expression analysis by RT-PCR. Total RNA was extracted from CPCs cultured on
scaffolds for 7, 14 and 21 days using RNeasy RNA Isolation kit (QIAGEN, Italy), following the
manufacturer’s protocol. The isolated RNA was dissolved in RNase-free water and the final
concentration of RNA was determined in a Qubit fluorometer (Invitrogen, USA). A total
amount of 100 ng RNA was reverse-transcribed into cDNA with QuantiTect Reverse Trascrip-
tion Kit (QIAGEN, Germany). All primers (Table 1) were designed with Primer3 software
[45]. RT-PCR was performed using RealMasterMix SYBR ROX (5Prime, Germany) according
to the manufacturer’s protocol. DNA amplification (10 ng of starting cDNA) was carried out
using Mastercycler ep realplex 4S (Eppendorf, Italy). The thermal cycling conditions included
an initial denaturation for 2 min at 95˚C and 40 cycles consisting of a denaturation step at
95˚C for 15 s, an annealing step at 58˚C for 15 s and an extension step for 30 s at 68˚C. The
binding of the fluorescence dye SYBR Green I (5Prime) to double-stranded DNA was mea-
sured. Samples were tested in triplicate with the housekeeping genes (GAPDH and RPL13A)
to correct for variations in RNA quality and quantity. Melt curve analyses were conducted to
assess uniformity of product formation, primer dimers formation and amplification of non-
specific products. Linearity and efficiency of PCR amplification were assessed by standard
curves generated by increasing amounts of cDNA. Comparative quantification of target genes
expression in the samples was performed based on cycle threshold (Ct) normalized to house-
keeping genes, using the ΔΔCt method.
In vivo tests
Animal model and implantation. Subcutaneous implantation of cell-free PU and
PU-LN1 scaffolds was performed in 6–8-week-old female FVB mice obtained from Charles
River Laboratories International, Inc.. In vivo tests were carried out with the aim to preliminar-
ily investigate body reaction (e.g. inflammation, integration, vascularisation) to the implanta-
tion of the newly designed PU and PU-LN1 scaffolds. In order to perform the same tests on
human CPC cellularized scaffolds, nude or immunosuppressed mice would have been
required, thus allowing in vivo assessment of the designed matrices in an environment that
poorly recapitulates the real in vivo situation, being immune response absent or suppressed.
Table 1. Primers designed with Primer3 software.
Gene Forward Primer Reverse Primer Amplicon
Length (nt)
GAPDH 5’-CACCATCTTCCAGGAGCGAG-3’ 5’-TCACGCCACAGTTTCCCGGA-3’ 372
NKX2.5 5’-CCTCAACAGCTCCCTGAC-3’ 5’-CTCATTGCACGCTGCATA-3’ 162
MEF2C 5’-AGGCAGCAAGAATACGATGC-3’ 5’-TACGGAAACCACTGGGGTAG-3’ 88
α-SA 5’-TCGGGACCTCACTGACTA-3’ 5’- GGGCTGGAAGAGTGTCTC-3’ 282
ETS1 5’-TGGGGACATCTTATGGGAAC-3’ 5’-TGGATAGGCTGGGTTGACTC-3’ 88
FVIII 5’-CAGCCTCTACATCTCTCAGTT-3’ 5’-ATGCGAAGAGTGCTGCGAATG-3’ 210
GATA6 5’- GCCCCTCATCAAGCCGCAGAA-3’ 5’- TCTCCCGCACCAGTCATCACC-3’ 378
SMA 5’-CTGAGCGTGGCTATTCCTTC-3’ 5’-TTCTCAAGGGAGGATGAGGA-3’ 133
https://doi.org/10.1371/journal.pone.0199896.t001
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Mice received humane care in compliance with the Italian law (DL-116, Jan. 27, 1992) and
the Guide for the Care and Use of Laboratory Animals published by the US National Institutes
of Health (NIH Publication No. 85–23, revised 1996). The study have been approved by the
Bioethics Committee of the University of Torino in 2011. All efforts were made to minimize
suffering. Intramuscular injections of 100 mg/kg ketamine (Pfizer, Italy) and 5 mg/kg xylazine
(Bayer, Italy) were applied to anesthetize the animals. The dorsal area of the animals was
shaved and sterilized with 70% ethanol solution. One incision was made on the back and a
subcutaneous pocket was created on each side. Mice were randomly assigned to 4 different
groups (PU 15 days, PU-LN1 15 days, PU 30 days, PU-LN1 30 days), and 3 mice per group
were subjected to implantation. The scaffold was subcutaneously implanted into each pocket
and incisions were closed with polypropylene sutures. Upon surgery, mice were monitored
once a day, 6 days per week. Mice were kept under controlled light (12/12 light /dark cycle) at
room temperature (22 ± 1˚C; U. R: 55 ± 10%). Food and water were provided ad libitum. The
analysis was performed in blind. At 15 and 30 days post-surgery, mice were euthanized with
CO2 asphyxiation followed by cervical dislocation, and implants were harvested for analysis.
Histology and immunochemistry. The implants and the surrounding tissues were fixed
in 4% PFA, dehydrated with graded ethanol series, embedded in paraffin, cut into 3-μm thick
sections and stained with hematoxylin and eosin (H&E; Bio-Optica, Italy) [46]. Blood vessels
in the tissues surrounding the implants were counted on H&E stained sections.
Statistical analysis
Statistical analysis was performed using GraphPad Prism ver. 6.0 for Windows (GraphPad
Software, La Jolla California USA, www.graphpad.com). One-way ANOVA analysis followed
by Tukey’s multiple comparison test was used to compare results. Statistical significance of
each comparison was assessed as reported by Boffito et al. [47]. Unpaired two-tailed t test was
used when indicated.
Results
Morphological characterization of scaffolds
Fig 1A provides a schematic representation of the computer-generated scaffold geometry,
while Fig 1B shows a representative Field Emission Gun Scanning Electron Microscopy
(FEG-SEM) image of a PU scaffold. The suitability of PU to be melt-extruded in self-support-
ing multi-layered structures was previously demonstrated [35]. Results of image analysis on
SEM micrographs showed a good agreement between the computer-generated geometry and
the obtained scaffolds (mean fiber diameter: 155 ± 3 μm, mean spacing: 500 ± 4 μm). Such
scaffold model geometry was here selected as it was characterized in our recent publication
[35].
Physico-chemical characterization of surface functionalized PU films and scaffolds.
Surface chemical properties of PU-based scaffolds were analyzed by X-ray Photoelectron Spec-
troscopy (XPS) analysis. Table 2 shows C, O and N elemental percentages and O/C and N/C
ratios on PU-based samples. The elemental composition of PU scaffolds reflected their chemis-
try, characterized by the presence of ester groups in the poly(ε-caprolactone) (PCL) diol and
urethane bonds along the PU chains. Plasma-treated PU showed a higher O percentage, attrib-
uted to the carboxylic groups of covalently grafted and polymerized acrylic acid. The O1s peak
(Fig 2A and 2B) showed that, in PU scaffolds, oxygen was due to carbonyl oxygen O-C = O
and ester/urethane oxygen O-C = O in nearly 60:40 ratio. After plasma treatment, the O1s
spectrum contained a third component for hydroxyl oxygen (C-O-H) (52.4%), with carbonyl
oxygen O-C = O and ester/urethane oxygen O-C = O being reduced to 39.6% and 8.0%,
Surface-functionalized scaffolds mimicking the myocardial microenvironment to support cardiac primitive cells
PLOS ONE | https://doi.org/10.1371/journal.pone.0199896 July 6, 2018 8 / 21
respectively, in agreement with previous papers [48, 49]. After protein grafting, N percentage
increased especially in the case of LN1 grafting while O/C ratio only slightly decreased com-
pared to plasma-treated PU scaffolds (Table 2).
The higher N percentage of PU-LN1 scaffolds vs. PU-G scaffolds can be attributed to the
higher amount of nitrogen rich residues (Asp, Glu, His, and Lys) of LN1 vs. G [50]. The C1s
core-level spectra of unmodified and modified PU (Fig 2C, 2D, 2E and 2F) were deconvoluted
into three main peaks at: 284.8 eV for carbon or carbon-hydrogen bonds (-C-C, -C-H), 286.0–
286.4 eV for carbon-nitrogen or carbon-oxygen bonds (C-N, C-O), and 287.8–288.9 eV for
carbonyl-like species (-COO-, C = O, -COOH at 288.9 eV, (C = O)-NH at 287.8 eV) [40, 42,
48, 49, 51]. In the C1s peak of plasma-treated PU, the contribution of C-C and C-H bonds
decreased and those of carbonyl and C-O bonds increased, suggesting successful acrylic acid
grafting/polymerization on the PU surface (Fig 2C and 2D). After protein grafting, the contri-
bution of carbonyl groups increased (especially in the case of PU-LN1 scaffolds) and slightly
shifted to lower eV (from 288.4 eV for plasma-treated PU scaffolds to 288.1 eV and 287.8 eV
for PU-G and PU-LN1 scaffolds, respectively) suggesting that the amount of N-C = O groups
increased due to protein grafting [40, 48, 49, 51].
Due to their different surface composition, PU-based samples also showed differences in
surface wettability. Static contact angle analysis performed on PU-based films is reported in
Fig 3A. PU films showed a contact angle of 89.1 ± 0.1˚. After plasma treatment with acrylic
Table 2. C, O and N percentages and O/C and N/C ratios, obtained from XPS analysis.
SAMPLE Atomic percentage (%)
C1s O1s N1s O/C N/C
PU 71.0 27.6 1.4 0.39 0.02
Plasma-treated PU 67.0 27.5 2.4 0.41 0.04
PU-LN1 64.1 23.5 12.4 0.37 0.19
PU-G 70.2 24.3 5.5 0.35 0.08
https://doi.org/10.1371/journal.pone.0199896.t002
Fig 1. Scaffold design and micrograph. (A) Overall scaffold dimensions (top left) and a zoomed view of the two
overlaying layers (bottom right) detailing fiber diameter (μm) and fiber-to-fiber distance (μm). (B) Representative
FEG-SEM micrograph of an additively manufactured PU scaffold.
https://doi.org/10.1371/journal.pone.0199896.g001
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acid, the static contact angle significantly decreased to 48.6 ± 1.5˚ confirming the grafting with
hydrophilic acrylic acid functionalities. Grafting with G or LN1 significantly increased the con-
tact angle to 61.3 ± 2.1˚ and 66.3 ± 0.8˚, respectively. No significant differences in wettability
were observed between PU-G and PU-LN1.
The successful introduction of–COOH groups by acrylic acid plasma treatment of PU scaf-
folds was further proved by Toluidine Blue O (TBO) colorimetric assay. After overnight incu-
bation in TBO solution, plasma-treated PU samples showed an intense blue color (S1 Fig)
Fig 2. High resolution XPS spectra. (A) O1s of PU scaffolds; (B) O1s of plasma-treated PU scaffolds; (C) C1s of PU scaffolds; (D) C1s of plasma-treated
scaffolds; (E) C1s of PU-G scaffolds and (F) C1s of PU-LN1 scaffolds.
https://doi.org/10.1371/journal.pone.0199896.g002
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associated with a significantly higher–COOH density (μmol/scaffold) vs. the control PU scaf-
folds, on which a lower density of TBO molecules was physically absorbed (Fig 3B). Scaffold
functionalization with LN1 was analyzed by ELISA assay (Fig 3C). An ELISA standard curve
(S2 Fig) was used to quantify LN1 amount on PU and PU-LN1 scaffolds through a regression
analysis. Data indicated a significant difference in the presence of LN1 on PU-LN1 and PU
scaffolds, demonstrating successful functionalization of PU-LN1 scaffolds.
In vitro cell tests results
CPC adhesion on scaffolds. Typically, 24 hours after seeding, cells adhered on the scaf-
folds and covered the filaments, spreading across the pores as observed by inverted phase con-
trast microscopy. Confocal image analysis revealed that the cells stretched out in three
dimensions, among the fibers in the same and in the adjacent scaffold layers (S3 Fig). At each
culture time, SEM micrographs (Fig 4A, 4B, 4C, 4D, 4E and 4F) showed higher cell engraft-
ment on PU-G and PU-LN1 scaffolds vs. PU scaffolds. After 14 days, cells spread on the scaf-
fold filaments, completely filling the pores. SEM analysis did not show significant differences
between PU-LN1 and PU-G scaffolds in terms of cellularization.
Proliferation and apoptosis of CPCs on scaffolds. Proliferation of CPCs on PU, PU-G
and PU-LN1 scaffolds was assessed by identifying and quantifying actively cycling Ki67-positive
cells. The proliferation-associated protein Ki67, which is expressed by cells from late G1, through
S and G2, to M phases, but not in resting cells in G0 cell cycle stage, was present in the cell nuclei.
At 7 days, the proportion of cycling cells reached the highest value on the PU-LN1 scaffolds
(18.56 ± 2.77%), exceeding 3.3 times the rate of Ki67-positive cells on PU (5.60 ± 1.15%) and
PU-G (5.66 ± 0.40%) scaffolds (n = 3, p<0.001). The rate of cycling cells in PU-LN1 scaffolds
decreased gradually over time; however, it remained higher than for the other scaffolds at each
time point (Fig 4G). At 7 days, apoptosis of CPCs cultured on PU-LN1 scaffolds was 2.4-fold
lower (2.44 ± 0.17%) respect to PU scaffolds (5.85 ± 1.15%, p<0.01) and 1.4-fold lower respect to
PU-G scaffolds (3.39 ± 0.45%; p = ns). These differences were sustained, if not augmented, with
time. Indeed, at 21 days the apoptosis rates were 3.58 ± 1.24% in PU scaffolds, 1.73 ± 0.12% in
PU-G scaffolds, and 1.05 ± 0.11% in PU-LN1 scaffolds (Fig 4H).
Gene expression of CPCs on scaffolds. The population of CD117-positive cells from
adult human heart consists of CPCs at different stages of their differentiation. The expression
of the transcription factors Nkx2.5 and Mef2C identifies putative cardiomyocyte progenitors.
Cardiomyocyte precursors differ from progenitors by the expression of cytoplasmic proteins,
such as α-sarcomeric actin (αSA). Endothelial and smooth muscle cell progenitors can be
identified by the expression of the transcription factor ETS1 and GATA6, respectively, while
the precursors of the respective cell lineages also express factor VIII (FVIII) or smooth muscle
actin (SMA) in the cytoplasm. The effect of scaffold functionalization on CPC differentiation
was evaluated through the expression of typical markers of primitive cardiomyocyte, endothe-
lial cell and smooth muscle cell lineages by Real-Time Quantitative Reverse Transcription-
Polymerase Chain Reaction (RT-PCR) (Fig 4I). Notably, at 7 days, the expression of markers
of cardiomyocyte (MEF2C, αSA), endothelial (ETS1, FVIII) and smooth muscle cell lineage
(GATA6 and SMA) was significantly higher in CPCs cultured on PU-LN1 scaffolds compared
Fig 3. Characterization of functionalization steps. (A) Static contact angle values of PU (PU), plasma-treated PU
(plasma-treated PU) and protein functionalized PU (PU-G and PU-LN1) films (n = 3;  p<0.0001;  p<0.001).
(B) Colorimetric quantification of–COOH surface density in PU and plasma-treated PU scaffolds by TBO assay (n = 3,
 p<0.0001). (C) Quantification of LN1 grafting by ELISA assay: mean values of deduced LN1 concentrations
measured on PU and PU-LN1 scaffolds (n = 3). Unpaired two-tailed t test was used for statistical analysis of data
(p< 0.01; p<0.0001).
https://doi.org/10.1371/journal.pone.0199896.g003
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to other experimental groups (Fig 4I). These differences were attenuated at 14 days, as the dif-
ferentiation of the CPCs proceeded, although at lower pace, also in the control group and on
the PU-G scaffolds. Nonetheless, even at 14 days, the expression of mRNA for cytoplasmic
proteins αSA and FVIII peaked in the presence of LN-1 and was 3.05 and 2.13-fold higher
than on the PU and PU-G scaffolds, respectively (Fig 4I). At 21 days, the lineage-specific char-
acteristics of CPCs were preserved and the expression of markers did not change significantly
(data not shown). PU-LN1 scaffolds were selected for further characterizations, such as in
vitro degradation tests and in vivo trials.
Fig 4. CPCs cultured on bare and surface-functionalized PU scaffolds: Cell morphology, proliferation, apoptosis
and gene expression. SEM micrographs of PU-based scaffolds cultured with human CPCs for 7 (on the left) and 14
days (on the right): (A, B) PU, (C, D) PU-G, (E, F) PU-LN1. Scale bar: 100 μm. (G) Proliferation, (H) apoptosis and
(I) gene expression of CPCs on PU scaffolds (control, white bars), PU-G scaffolds (grey bars) and PU-LN1 scaffolds
(black bars) at different time points. p<0.05, p<0.01, p<0.001 vs. control, #p<0.05, ##p<0.01, ###p<0.001 vs.
PU-G scaffolds.
https://doi.org/10.1371/journal.pone.0199896.g004
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In vitro degradation tests on PU and PU-LN1 scaffolds
Hydrolytic and enzymatic degradation tests were performed on PU and PU-LN1 scaffolds to
assess any effect of functionalization on degradation kinetics. Fig 5 shows the weight loss as a
function of time for PU and PU-LN1 scaffolds in the case of hydrolytic (Fig 5A) and enzymatic
degradation (Fig 5B), the Number Average Molecular Weight (Mn) percentage loss as a func-
tion of time for PU scaffolds (Fig 5C), and SEM micrographs of the surface morphology of
PU-LN1 scaffolds (Fig 5D) during both hydrolytic and enzymatic degradation. Enzymatic deg-
radation was complete after 3 weeks (Fig 5B and 5C), while Mn loss due to hydrolytic degrada-
tion was only 5% after 8 weeks incubation in Phosphate Buffered Saline (PBS, pH 7.4) (Fig
5C). SEM analysis (Fig 5D) showed that PU-LN1 samples did not change their morphology
during hydrolytic degradation tests, while samples incubated in the lipase-containing medium
developed surface cracks. The viability of NIH-3T3 cells was evaluated in contact with the
products of the complete degradation of PU scaffolds incubated in lipase medium following a
Fig 5. Hydrolytic and enzymatic degradation of bare and LN1-functionalized PU scaffolds: Weight loss, changes
in morphology, loss of molecular weight and cytotoxicity of degradation products. Weight loss profiles of PU and
PU-LN1 scaffolds undergoing (A) hydrolytic and (B) enzymatic degradation. (C) Mn loss profiles of PU scaffolds
during hydrolytic and enzymatic degradation. (D) SEM micrographs of PU-LN1 scaffolds during hydrolytic and
enzymatic degradation. (E) Viability of NIH-3T3 cells in the presence of Dulbecco’s Modified Eagle’s Medium
(DMEM) containing PU degradation products (0.1 mg/mL) compared to control conditions, as evaluated by Cell Titer
Blue assay (n = 4).
https://doi.org/10.1371/journal.pone.0199896.g005
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previously developed method [52]. Results (Fig 5E) showed that no significant differences in
cell viability were detected in the presence or in the absence of the degradation products.
Results from in vivo tests
PU and PU-LN1 scaffolds were subcutaneously implanted in mice to evaluate their biocom-
patibility and tissue response. All animals remained in good health during the experiments
without signs of pain and macroscopic inflammation. After 15 and 30 days, mice were eutha-
nized and the implants removed for further analysis. No signs of degradation or resorption
were observed. Histological analysis demonstrated a good incorporation in the host tissues,
with skeletal muscle, adipose and dermal tissues surrounding the scaffold fibers (Fig 6A). No
differences were observed between PU and PU-LN1 scaffolds: no signs of inflammation,
abscess formation, tissue necrosis or damage were present (Fig 6A). The number of blood ves-
sels in the tissues surrounding the implants (Fig 6B) were not statistically different in both PU
and PU-LN1 scaffolds (Fig 6C).
Discussion
In this work, scaffolds mimicking the composition of the cardiac ECM were developed with the
aim to positively affect CPC behavior, in terms of cell attachment, proliferation, viability and
differentiation towards cardiomyocytes, endothelial and smooth muscle cells. In the literature, a
number of scaffolds have been proposed for CPC-based therapy for myocardial regeneration,
using synthetic materials [32–35], natural polymers [24], or their combinations [25]. The versa-
tility of polyurethane chemistry for TE applications has been previously demonstrated [35, 36,
40, 47, 53]. A previously designed biocompatible PU [35] was here successfully processed by
melt-extrusion AM, obtaining bi-layered scaffolds with a 0˚/90˚ lay-down pattern (Fig 1).
Selected fiber size and spacing allowed the deposition of self-supporting molten filaments dur-
ing the fabrication of highly porous scaffolds. In our previous study, such scaffold geometry was
found to support CPC adhesion and spreading [35]. However, CPCs could not proliferate on
pristine PU scaffolds [35], suggesting the need for a biomimetic surface functionalization, that
was investigated in the present work. A two-step plasma treatment was applied to PU scaffolds
to surface graft/polymerize acrylic acid which was then exploited for carbodiimide-mediated
conjugation of proteins [40]. Plasma treatment is a highly versatile tool for surface functionali-
zation of polymeric substrates without affecting bulk material properties [54]. The literature
also reports recently introduced challenging methods for polymer surface functionalization,
such as mussel inspired protein-mediated surface functionalization [55–58], which offers the
possibility to uniformly deposit biomolecules on complex surfaces, e.g. nanopatterned sub-
strates, similarly to plasma approach. However, the detailed mechanism of DOPA-mediated
surface functionalization is still under scientific debate, while plasma technology has already
been introduced in industrial processes owing to its capability of treating objects with irregular
and complicated shapes, the high control of all treatment parameters and steps, and its low cost.
Successful acrylic acid grafting/polymerization was demonstrated by XPS (Fig 2, Table 2)
and static contact angle measurements (Fig 3A), and quantified by TBO assay (Fig 3B). Based
on previous findings [27,28], LN1 was here selected as a target protein for scaffold surface
functionalization, while G was chosen as a control molecule, as it is a low-cost protein, com-
monly used for cell culture experiments. Successful grafting of the proteins was confirmed by
XPS (Fig 2, Table 2), static contact angle measurements, and ELISA assay (Fig 3A and 3C).
PU-G and PU-LN1 scaffolds supported CPC adhesion (Fig 4, S3 Fig). Additionally, LN1 con-
jugated to the scaffold surface retained its ability to promote CPC proliferation (Fig 4G) and
protect CPCs from apoptosis (Fig 4H), as previously demonstrated by Castaldo et al. for LN1
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physically absorbed on Petri dishes [27]. PU-LN1 scaffolds were significantly superior to pris-
tine PU and PU-G scaffolds in supporting CPC proliferation and protecting cells from apopto-
sis. Both PU-G and PU-LN1 scaffolds increased the differentiation commitment of CPCs to
cardiomyocytes, smooth muscle and endothelial cells; however, CPC differentiation proceeded
at a significantly higher pace when cultured on PU-LN1 scaffolds (Fig 4I). The effect of LN1
was particularly relevant considering that neither a differentiation culture medium nor a bio-
mimetically-inspired scaffold architecture were additionally used to influence CPC behavior.
Due to their superior properties, PU-LN1 scaffolds were selected and further analyzed for their
in vitro degradation kinetics and in vivo tissue compatibility. Scaffold incubation in lipase solu-
tions was here applied to demonstrate the complete biodegradability of the PU scaffolds and
the cytocompatibility of their degradation products (Fig 5E) [59]. PU-LN1 and PU scaffolds
underwent fast degradation by lipase through surface erosion (Fig 5D), while hydrolytic
Fig 6. Results from in vivo tests carried out in mice: Histological analysis and quantification of blood vessels in
the tissues surrounding the implants. Histological analysis by hematoxylin and eosin staining of PU and PU-LN1
scaffolds and surrounding tissues explanted 15 (A) and 30 (B) days following subcutaneous implantation in mice.
Arrows indicate blood vessels (scale bar: 50 μm). (C) Number of blood vessels per mm2 in the tissues surrounding PU
and PU-LN1 scaffolds, and explanted 15 and 30 days after subcutaneous implantation in mice. Unpaired two-tailed t
test was used for statistical analysis.
https://doi.org/10.1371/journal.pone.0199896.g006
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degradation was slow (Fig 5A, 5C and 5D) and proceeded through a bulk degradation mecha-
nism (Fig 5D). Both mechanisms mainly involve the rupture of PCL ester bonds along the PU
chains. Although LN1 functionalization increased the surface wettability compared to PU sam-
ples, its presence did not significantly affect the degradation rate. PU and PU-LN1 scaffolds
subcutaneously implanted in mice were well incorporated in the host tissues and no signs of
resorption or severe inflammation were observed up to 30 days (Fig 6A). Subcutaneous implan-
tation of cardiac scaffolds has been previously performed as a preliminary test to analyze scaf-
fold integration and vascularization [32, 60–62]. Particularly, respect to what found by Liu et al.
for their non-cellularized nanofibrous poly(L-lactic) acid scaffolds [32], our non-cellularized
PU-LN1 scaffolds supported long term angiogenesis (Fig 6B and 6C). Angiogenesis might be
further improved by implanting cellularized PU-LN1 scaffolds due to a paracrine effect exerted
by the cells, as previously demonstrated [32]. The obtained results open important perspectives
in the field of CPC-based therapies, as they demonstrate enhanced in vitro survival, proliferation
and differentiation of CPCs on PU scaffolds functionalized with a biomimetic protein of cardiac
ECM (LN1) compared to scaffolds grafted with a non-cardiac mimetic cell-adhesive protein
(G). To our knowledge, a chemical stimulation of human CPCs through the scaffold surface
chemistry has not been exploited up to now and could be further combined with mechanical,
electrical or topological cues with the aim to facilitate CPC differentiation into mature cardio-
myocytes. Based on these results and previous literature [25], in the future, we will prepare
PU-LN1 scaffolds more closely mimicking CPC niche microenvironment combining chemo-
tactic signaling (LN1 functionalization) with biomimetic anisotropic architecture to analyze
their influence on CPC maturation and differentiation, Importantly, such new scaffolds mim-
icking cardiac niche could be also exploited for in vitro studies of human CPCs behavior in a
biomimetic 3D environment, which is more representative of the in vivo condition. Addition-
ally, our results could have further impact by inspiring new approaches based on the use of
LN1-functionalized scaffolds to facilitate in vitro differentiation of pluripotent stem cells into
the cardiac phenotype or even the direct reprogramming of fibroblasts into cardiomyocytes.
Conclusions
In this work, PU scaffolds were prepared by melt-extrusion AM technique and successfully
surface functionalized with LN1 and G (as a control molecule for functionalization) by plasma-
mediated grafting. Although both PU-G and PU-LN1 scaffolds showed increased cell density
compared to pristine PU scaffolds, LN1 functionalization resulted in improved protection of
CPCs from apoptosis and promotion of CPC proliferation, stimulating their differentiation to car-
diomyocytes, endothelial cells and smooth muscle cells at a higher pace than G. PU and PU-LN1
scaffolds did not undergo significant hydrolytic degradation in vitro up to 8 weeks; however, their
biodegradation ability was demonstrated by in vitro enzymatic degradation tests. Enzymatic deg-
radation products were cytocompatible. Similarly, PU-LN1 and PU scaffolds, subcutaneously
implanted in a mouse model, evoked a minimal inflammatory response and promoted angiogene-
sis. Hence, this work demonstrated the ability of PU-LN1 scaffolds to positively affect CPC behav-
ior, being LN1 a key component of cardiac niche ECM. Results from this study were the first
evidence of the possible application of PU-LN1 scaffolds as in vitro models of myocardial micro-
environment with the aim to study CPC behavior, or as implantable patches for myocardial TE.
Supporting information
S1 Fig. Photos of scaffolds after TBO assay. Typical aspect of untreated PU control scaffolds
(PU) and plasma treated PU scaffolds (Plasma-treated PU) after TBO colorimetric assay.
(TIF)
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S2 Fig. ELISA standard curve for LN1. A second order polynomial best-fit curve was used to
generate a regression formula (R2 = 0.95). LN1 concentrations were deduced through regres-
sion using GraphPad program.
(TIF)
S3 Fig. Morphology of CPC cultured on pristine and surface-functionalized PU scaffolds
for 7 days. Representative images of CPCs cultured for 7 days on PU (A, D), PU-G (B) and
PU-LN1 (C) scaffolds observed by phase contrast microscopy (A, B, C) and confocal micros-
copy after actin cytoskeleton (green) and nuclei (red) staining on PU scaffolds (D). Scale bar is
200 μm.
(TIF)
S1 File. NC3Rs ARRIVE guidelines checklist.
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